Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › P2X3, receptor antagonists for treatment of pain

P2X3, receptor antagonists for treatment of pain

US Patent 8598209 · Granted Dec 3, 2013

Estimated economic value: $75,696,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydroquinazoline derivatives as selective cytotoxic agents2025
Pyrrolidine orexin receptor agonists2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
MrgX2 antagonists2024
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
Tetrahydroquinazoline derivatives as selective cytotoxic agents2023
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in v2021